Risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriers

Risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriers - Risk reducing salpingo-oophorectomy in BRCA1/2 mutant carriers

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037086

Enrollment

Registered

2019-06-17

Start date

2017-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditary breast and ovarian cancer

Interventions

risk reducing salpingo-oophorectomy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. BRCA1/2 mutant carriers 2. Women who give informed consent about risk reducing salpingo-oophorectomy

Exclusion criteria

Exclusion criteria: 1. Women who desire having babies 2. Women with ovarian or tubal cancer 3. Physician decision

Design outcomes

Primary

Measure	Time frame
Perioperative complications related to risk reducing salpingo-oophorectomy	—

Countries

Japan

Contacts

Public ContactKentaro Nakayama

Shimane University Faculty of Medicine Department of Obstetrics and Gynecology

kn88@med.shimane-u.ac.jp+81-853-20-2268

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026